Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M87.7Revenue (TTM) $M33.9Net Margin (%)14.0Altman Z-Score1.0
Enterprise Value $M105EPS (TTM) $0.1Operating Margin %7.0Piotroski F-Score4
P/E(ttm)14.8Beneish M-Score2.5Pre-tax Margin (%)2.1Higher ROA y-yY
Price/Book1.810-y EBITDA Growth Rate %--Quick Ratio1.3Cash flow > EarningsN
Price/Sales2.65-y EBITDA Growth Rate %57.5Current Ratio2.1Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)6.3Higher Current Ratio y-yN
Dividend Yield %--PEG0.3ROE % (ttm)11.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M78.0ROIC % (ttm)6.3Gross Margin Increase y-yY

Gurus Latest Trades with NEPT

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

NEPT is held by these investors:



NEPT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Montgomery, Adrian TaylorDirector 2014-12-03Buy11,000$2.21-48.87view
Godin, AndréSenior Officer 2014-11-12Buy3,000$2.15-47.44view
Lemieux, PierreDirector or Senior Officer of Insider or Subsidiar 2014-11-12Buy5,000$2.19-48.4view
Godin, AndréSenior Officer 2014-11-11Buy8,000$2.12-46.7view
Ripplinger, JohnSenior Officer 2014-11-11Buy3,550$2.12-46.7view
Turcotte, MarioSenior Officer 2014-11-11Buy6,870$2.14-47.2view
Fitzgibbon, PierreDirector 2014-11-10Buy37,500$2.09-45.93view
Huart, BenoîtDirector 2014-11-10Buy7,000$2.03-44.33view
Lauzon, ClaudieSenior Officer 2014-11-10Buy2,400$2.08-45.67view
Le Bel, DominiqueSenior Officer 2014-11-10Buy10,000$2.01-43.78view

Press Releases about NEPT :

Quarterly/Annual Reports about NEPT:

    News about NEPT:

    Articles On GuruFocus.com
    Neptune and Enzymotec Reach Patent Agreement Ending All Litigation Apr 03 2017 
    Acasti Pharma Reports Second Quarter 2017 Financial Results Oct 11 2016 
    Neptune and Ingenutra Sign an Exclusive Worldwide Agreement for MaxSimil® Oct 07 2016 
    Neptune and Aker BioMarine Reach Important Patent Agreement, Recognizing the Patents' Strength and E Oct 03 2016 
    Neptune to Hold Conference Call to Discuss Second Quarter Results for the Period Ended August 31, 20 Sep 28 2016 
    NEPTUNE Introduces NKO(R) Omega Plus, a New and Innovative Krill Oil Product with one of the Highest Sep 15 2016 
    Acasti Pharma Reports Positive CaPre Omega-3 Bridging Study Data Sep 15 2016 
    Neptune to Hold Conference Call to Discuss First Quarter Results for the Period Ended May 31, 2016 Jun 30 2016 
    Neptune Announces Fourth Quarter and Fiscal Year Results May 25 2016 
    Acasti Announces Fourth Quarter and Fiscal Year Results May 25 2016 

    More From Other Websites
    Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year-End Results for the... May 18 2017
    Acasti Pharma Presents CaPre Clinical Data at National Lipid Association Scientific Sessions May 18 2017
    Unique Medical Cannabis Partnership Announced, Creating Scientific and Business Development Hub in... May 16 2017
    Acasti Granted Additional Composition & Use Patents in Taiwan and Australia; Safeguards Valuable... Apr 24 2017
    Acasti Pharma to Present CaPre Omega-3 Bridging Study Results at National Lipid Association... Apr 12 2017
    Neptune enters into Commercial Distribution Joint Venture in China with Shanghai Chonghe Marine... Apr 05 2017
    Neptune and Enzymotec Reach Patent Agreement Ending All Litigation Apr 03 2017
    Neptune and Enzymotec reach Patent Agreement Ending All Litigation Apr 03 2017
    Acasti Pharma Forms Scientific Advisory Board and Appoints Two Leading Cardiovascular Disease... Mar 08 2017
    Acasti Pharma Grants Incentive Stock and Options Feb 24 2017
    Neptune to Present at ROTH Capital Partners 29th Annual Growth Stock Conference Feb 22 2017
    Acasti Pharma Announces Proposed Private Placement of Convertible Debentures and Amended Proposed... Feb 02 2017
    Neptune Technologies & Bioresources, Inc. :NEPT-US: Earnings Analysis: Q3, 2017 By the Numbers :... Jan 18 2017
    Neptune Tech posts 3Q profit Jan 12 2017
    Acasti Pharma Reports Third Quarter 2017 Financial Results Jan 12 2017
    Neptune Announces Record Third Quarter Results Jan 12 2017
    Neptune to Hold Conference Call to Discuss Third Quarter Results for the Period Ended November 30,... Jan 04 2017
    Validity of Neptune's Patent Upheld by Australian Patent Office Nov 07 2016
    Neptune Announces Stock Ticker Symbol Change to NEPT on the TSX Nov 04 2016
    Acasti Announces Stock Ticker Symbol Change to ACST on the TSXV Nov 03 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)